La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Gait Disorders, Neurologic (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Gait Disorders, Neurologic (diagnosis) < Gait Disorders, Neurologic (drug therapy) < Gait Disorders, Neurologic (epidemiology)  Facettes :

List of bibliographic references indexed by Gait Disorders, Neurologic (drug therapy)

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000249 (2016) Fariborz Rahimi [Iran] ; Angela C. Roberts [États-Unis] ; Mandar Jog [Canada]Patterns and predictors of freezing of gait improvement following rasagiline therapy: A pilot study.
000314 (2016) F. Pieruccini-Faria [Canada] ; J A Jones [Canada] ; Q J Almeida [Canada]Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
000678 (2015) Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni]Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
000748 (2015) Mariano Serrao [Italie] ; Alberto Ranavolo [Italie] ; Carmela Conte [Italie] ; Chiara Davassi [Italie] ; Silvia Mari [Italie] ; Alfonso Fasano [Canada] ; Giorgia Chini [Italie] ; Gianluca Coppola [Italie] ; Francesco Draicchio [Italie] ; Francesco Pierelli [Italie]Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.
000828 (2015) Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease.
001756 (2011) Deepak Gupta [Canada] ; Abraham Kuruvilla [Inde]Vascular parkinsonism: what makes it different?
002992 (2005) Marguerite Wieler [Canada] ; Richard Camicioli ; C Allyson Jones ; W R Wayne MartinBotulinum toxin injections do not improve freezing of gait in Parkinson disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Gait Disorders, Neurologic (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Gait Disorders, Neurologic (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Gait Disorders, Neurologic (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022